Taxotere Drug Lawsuit Source

Taxotere Chemotherapy Lawsuits

Since 1996 when it was first approved by the FDA, Taxotere has been one of the most prescribed chemotherapy drugs in its class.

Doctors and cancer patients have preferred treatment with Taxotere for years because unlike other similar drugs, it must only be administered once every three weeks. Similar cancer treatment medications require more frequent visits, which often produce the same results as Taxotere.

Unfortunately, patients who have received Taxotere chemotherapy have been experiencing some unexpected side effects that were not disclosed by the manufacturer, and this has led to many lawsuits being filed against Sanofi-Aventis.

Many female cancer patients have reported hair loss after undergoing treatment with Taxotere. While hair loss during chemotherapy is not unusual, and certainly not a cause to file a lawsuit, these patients have not regrown hair months, even years after finishing chemotherapy.

Hair loss from chemotherapy can produce a condition known as alopecia, which occurs when hair follicles inside the body are mistakenly attacked, in this case, due to the chemotherapy medication. Alopecia causes patches of hair to fall out on the scalp, as well as in other places on the body. Normally, alopecia is temporary, and normal hair growth will return after chemotherapy treatment is complete.

The permanent hair loss experienced by some patients can have a profound effect on quality of life, even after the cancer has been destroyed or entered remission. For this reason, many women have filed lawsuits requesting compensation for the emotional suffering they have endured.

What are the Criteria for Filing a Taxotere Lawsuit?

Taxotere (docetaxel) is a chemotherapy drug approved in the treatment of breast cancer along with other forms of cancer. It is administered intravenously through a vein, and is a member of a family of drugs called taxanes.

In 2007, manufacturer Sanofi-Aventis issued a press release touting the efficacy of Taxotere based on a clinical study. However, Sanofi-Aventis failed to inform the FDA, health care providers, and the public that permanent hair loss was observed in a number of the patients taking Taxotere.

In December 2015, the FDA announced it had ordered Sanofi-Aventis to change Taxotere’s label to warn patients of the risk of permanent hair loss. While hair loss during chemotherapy is expected, patients undergoing chemotherapy with Taxotere were not warned they could potentially experience permanent hair loss.

Permanent hair loss is an extremely debilitating condition, especially for women. We are currently investigating claims for women who suffered permanent hair loss following chemotherapy with Taxotere for breast cancer.

The following criteria must be met to file a Taxotere hair loss claim:

  • Diagnosed with stage 1 or 2 breast cancer
  • Underwent chemotherapy as part of treatment
  • Taxotere was used in chemo
  • Hair loss occurred where hair has not returned and chemo treatment was completed at least six months prior
  • Must have photos of hair loss before and after
  • Hair loss includes eyebrows and eyelashes

The Case Against Taxotere

Several female breast cancer survivors have recently filed lawsuits against Sanofi-Aventis, the producer of Taxotere.

Along with claims of permanent hair loss come allegations that Sanofi knowingly hid or did not disclose research that suggested permanent alopecia was a potential side effect. As of today, there is still no warning label on Taxotere suggesting the possibility of this side effect.

For cancer survivors, hair loss is more than meets the eye. It is a constant reminder of the struggle they have endured. For young women especially, hair loss can be incredibly difficult to cope with. Adding insult to injury, many permanent alopecia victims believe that Sanofi-Aventis should have been aware of this side effect. In fact, the lawsuits specifically name studies that were conducted decades ago that point to permanent hair loss as a complication of Taxotere.

1998 NEJM Study

Sanofi sponsored a study that looked to prove the effectiveness of taxane-based chemotherapy over non-taxane-based treatment. Although the study did identify an increased effectiveness of taxane treatment in certain types of cancer, it also identified a nearly 10% occurrence of permanent hair loss in women who were given Taxotere. The lawsuits against Sanofi allege that by the mid 2000s, the company was aware of this permanent hair loss.

2006 Study by Dr. Scot Sedlacek

In 2006, Dr. Scot Sedlacek, an oncologist in Denver, Colorado, noted in his research that Taxotere may be responsible for more than 6% of women who undergo treatment to suffer permanent hair loss. Dr. Sedlacek has been outspoken about the seriousness of alopecia and the damage it can cause to patients, even after the cancer has been removed.

Previous Legal Troubles

The allegations of hidden study results should not come as a surprise to many, as this is not the first time Sanofi has been reprimanded for unethical practices.

In 2007, the big pharma giant was ordered to pay more than $190 million to the United States government to settle a breach of the False Claims Act.

The United States claimed Sanofi engaged in a pricing scheme for their antiemetic drug Anzemet, used to prevent nausea during cancer radiation therapy. It was alleged the company maintained inflated prices for the drug, as government programs had established reimbursement rates based on the fraudulent prices.

It is expected that more cancer survivors who have yet to grow back hair after taking taxotere will soon come forward with more lawsuits. At this time, it is unclear if these lawsuits will be consolidated into a class action lawsuit or multi-district litigation. However, if you have suffered a similar fate, our attorneys can help you determine the right path to recovering compensation.

How Do I File My Taxotere Hair Loss Lawsuit?

If you are female, and have received chemotherapy treatment with Taxotere that has caused permanent hair loss, you may be able to file a lawsuit and recover compensation. Our chemotherapy hair loss lawyers are investigating cases for people who were not warned of this life changing side effect. We can help you!

Simply call us and explain your situation to us. We will listen and advise you on your best option to pursue compensation. The process could not be simpler. Best of all, we do not charge anything to represent you. In fact, the whole process will cost you nothing at all. We will pay for all case costs and litigation expenses during the lawsuit. Only after we win your settlement will you be responsible for payment. This is our No Fee Promise to you.

Start Your Taxotere Hair Loss Claim

Our chemotherapy hair loss lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-3417 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Taxotere hair loss lawsuit claims.

Drug Lawsuit Source Lawyer Reviews & Attorney Testimonials

Drug Lawsuit Source Client Review
Review Date
Reviewed
Prescription Drug Lawyer
Client Rating
51star1star1star1star1star

Taxotere News – Lawsuits, Settlements, Information

View Sources

  1. Taxotere Safety Communicatio – FDA
  2. How To Treat Hair Loss Quickly – Positive Health Awareness
  3. Docetaxel – National Cancer Institute

References